Skip to main content
Elevance Health, Inc.
Healthcare · Healthcare Plans
Made on Aug 11, 2026
Price at call $397.70
6-month call Bull +5.1%
Target by Feb 2027 $418.00
Great value below $340.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +5.1% to $418.00
Predicted High $418.00 at 6 months
Predicted Low $392.50 at 1 month
Max Drawdown (predicted) -1.3%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 11, 2026 1:20 am
Bull ELV trends higher to $418.00 (+5.1% from $397.70) by Feb 2027. dip-then-recover
ThesisELV screens cheap on DCF and composite fair value but quality and sentiment are negative, and the stock has quietly gained 17% over 6 months on near-zero beta. With no earnings catalyst in the window and value gravity working slowly, expect a modest drift higher toward the signal-adjusted anchor, punctuated by a soft patch as the recent rally digests.
Invalidated ifA break below $360 on managed-care headline risk, or failure to reclaim $410 by November, would falsify the slow-grind-higher thesis.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $397.70 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 11, 2026 $397.70 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 25, 2026 $368.22–$427.18 typical range · internal point $396.00 ±7.4% 6/10 Low-beta drift, no catalyst, mild digestion of recent run
1 month Sep 11, 2026 $354.98–$440.42 typical range · internal point $392.50 ±10.7% 5/10 Sentiment fade and quality headwind pull toward $390 support
2 months Oct 11, 2026 $399.00 +0.3% 4/10 Stabilization ahead of Q3 print expectations building
3 months Nov 11, 2026 $408.00 +2.6% 5/10 Earnings beat streak likely extends, matches baseline endpoint
4 months Dec 11, 2026 $412.00 +3.6% 4/10 Year-end positioning into defensive low-beta names
5 months Jan 11, 2027 $415.00 +4.4% 4/10 Value gravity toward signal-adjusted $405 already cleared
6 months Feb 11, 2027 $418.00 +5.1% 3/10 Slow convergence toward composite fair value continues

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $408.04 (+2.6%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 0 notes — follow the chain top-down (cause → effect).
  • Degraded
    [critical] High debt risk — interest coverage dangerously low or refinancing needed
    upstream:valuation-synthesis

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$397.70
Composite fair value$496.79
Signal-adjusted fair value$405.25
DCF fair value$462.46
Anchored-PE fair value$690.50
Buy-below (value lens)$340.00
Value net score-20
Value confidence7 / 10
Quality net score-27
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 43.1%  3m 37.2%  6m 35.6%  
Daily σ (realism noise)2.3%
Beta vs S&P 500 1m 0.50  3m 0.05  5m 0.24  
Trailing 6-month return17.3%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 11, 2026 freshest ELV-20260811-000713-01d8
ext-forensic-memo Aug 11, 2026 freshest ext-ELV-20260811-010850-64e3
ext-lens-quality Aug 11, 2026 freshest ext-ELV-20260811-010850-64e3
ext-lens-sentiment Aug 11, 2026 freshest ext-ELV-20260811-010850-64e3
ext-lens-value Aug 11, 2026 freshest ext-ELV-20260811-010850-64e3
scenario-valuation Aug 11, 2026 freshest ELV-20260811-000713-01d8
valuation-synthesis Aug 11, 2026 freshest ELV-20260811-000713-01d8

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 11, 2026 v0.6.0 Bull $397.70 $418.00 +5.1% Feb 2027 viewing
Jul 10, 2026 v0.3.0 Bull $420.39 $457.65 +8.9% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.